Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 159

    1.

    Using information technology to transfer knowledge: a medical institution steps up to the plate.

    Badgett R, Mulrow C.

    Ann Intern Med. 2005 Feb 1;142(3):220-1. No abstract available. PMID: 15684213 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Responding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providers.

    Jain A, Atreja A, Harris CM, Lehmann M, Burns J, Young J.

    Ann Intern Med. 2005 Feb 1;142(3):182-6.PMID: 15684206 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Was Vioxx really that dangerous?

    Park A.

    Time. 2005 Feb 28;165(9):52. No abstract available. PMID: 15765852 [PubMed - indexed for MEDLINE]Related articles

    4.

    Merck withdraws Vioxx; FDA issues public health advisory.

    [No authors listed]

    FDA Consum. 2004 Nov-Dec;38(6):11. No abstract available. PMID: 15675020 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Ten lessons to be learned from the withdrawal of Vioxx (rofecoxib).

    Carné X, Cruz N.

    Eur J Epidemiol. 2005;20(2):127-9. No abstract available. PMID: 15792277 [PubMed - indexed for MEDLINE]Related articles

    6.

    The changing landscape for COX-2 inhibitors: a summary of recent events.

    Mamdani M.

    Healthc Q. 2005;8(2):24, 26. No abstract available. PMID: 15828561 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Stepping into the Vioxx void. Answers to four questions after the popular pain reliever was yanked off the market.

    [No authors listed]

    Harv Health Lett. 2005 Jan;30(3):6. No abstract available. PMID: 15773006 [PubMed - indexed for MEDLINE]Related articles

    8.

    The Vioxx debacle.

    Alpert JS.

    Am J Med. 2005 Mar;118(3):203-4. No abstract available. PMID: 15745713 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall]

    Meyer CH.

    Klin Monbl Augenheilkd. 2005 Jan;222(1):62-3. German. No abstract available. PMID: 15678404 [PubMed - indexed for MEDLINE]Related articles

    10.

    Vioxx, the implosion of Merck, and aftershocks at the FDA.

    Horton R.

    Lancet. 2004 Dec 4-10;364(9450):1995-6. No abstract available. PMID: 15582041 [PubMed - indexed for MEDLINE]Related articles

    11.

    Discontinuation of Vioxx.

    McLean TR.

    Lancet. 2005 Jan 1-7;365(9453):25; author reply 27-8. No abstract available. PMID: 15639673 [PubMed - indexed for MEDLINE]Related articles

    12.

    Discontinuation of Vioxx.

    Garattini S, Bertelé V.

    Lancet. 2005 Jan 1-7;365(9453):24. No abstract available. PMID: 15639671 [PubMed - indexed for MEDLINE]Related articles

    13.

    Discontinuation of Vioxx.

    Nutt DJ.

    Lancet. 2005 Jan 1-7;365(9453):28. No abstract available. PMID: 15639676 [PubMed - indexed for MEDLINE]Related articles

    14.

    Discontinuation of Vioxx.

    Boers M.

    Lancet. 2005 Jan 1-7;365(9453):25-6; author reply 26-7. No abstract available. PMID: 15639672 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cyclooxygenase-2 inhibitors and cardiovascular risk.

    Smith ER.

    Can J Cardiol. 2005 Mar;21(3):307-8. English, French. No abstract available. PMID: 15776124 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lessons on prescribing and drug safety from the withdrawal of rofecoxib.

    Nelson M, Cicuttini F.

    Aust Fam Physician. 2004 Dec;33(12):965-6. No abstract available. PMID: 15630913 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Probable cardiac failure due to rofecoxib]

    García Nicolás FJ.

    Aten Primaria. 2005 Apr 15;35(6):325-6. Spanish. No abstract available. PMID: 15826518 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The Vioxx debacle revisited.

    Mohapatra PR, Janmeja AK.

    Am J Med. 2005 Sep;118(9):1058. No abstract available. PMID: 16164909 [PubMed - indexed for MEDLINE]Related articles

    19.

    Discontinuation of Vioxx.

    Kim PS, Reicin AS.

    Lancet. 2005 Jan 1-7;365(9453):23; author reply 26-7. No abstract available. PMID: 15639669 [PubMed - indexed for MEDLINE]Related articles

    20.

    Drug safety. FDA panel urges caution on many anti-inflammatory drugs.

    Couzin J.

    Science. 2005 Feb 25;307(5713):1183-5. No abstract available. PMID: 15731414 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data